The increasing problem of drug-resistant Plasmodium strains means that new therapies are urgently needed to treat this devastating disease. 3 Historically, natural products have played a major role in the treatment of malaria. [4] [5] [6] [7] For centuries the indigenous people from South America have used the bark from the "fever tree", Cinchona succiruba for the treatment of malaria. Similarly, the Chinese medicinal plant, Artemisia annua, commonly known as Qinghao, has been used in China as an antimalarial herbal remedy for hundreds of years. [4] [5] [6] [7] Subsequent chemical investigations of Cinchona succiruba and Artemisia annua identified the major active metabolites to be quinine and artemisinin (Qinghaosu), respectively. [4] [5] [6] [7] Artemisinin is considered one of the most important discoveries in contemporary herbal research.
Traditional Chinese medicine (TCM) has been regarded as a national heritage for centuries. Approximately 13,000 kinds of medicinal plants have been recorded in China. 8 Among them, over 300 are commonly used for antimalarial remedies. In our  Corresponding authors. Ronald Quinn, tel.: +0061-7-37356000; fax: +0061-7-37356001, e-mail: r.quinn@griffith.edu.au; Yunjiang Feng, tel.: +0061-7-37356014, fax: +0061-7-37356001, email: y.feng@griffith.edu.au ongoing effort in understanding TCM and its action, a collaborative research project was established to investigate antimalarial traditional Chinese medicinal plants. The objective of the project was not only to identify antimalarial natural products, but also to investigate whether a TCM's action is solely associated with a single active component, an underlying philosophy of western medicine. One hundred antimalarial Chinese medicinal herbs recorded in the Chinese Pharmacopeia were selected and tested in vitro against the malaria parasite Plasmodium falciparum 3D7 for antimalarial activity. Of these, 82 extracts showed >50% inhibition at 10 mg/mL, while 35 had >90% inhibition at the same concentration. These results largely confirmed the traditional knowledge of the antimalarial activity of the herbal medicines recorded in the Chinese Pharmacopiea. The crude extract from the rhizomes of a Tibetan Picrorhiza scrophulariiflora Pennell showed potent activity and was chemically investigated. Flash chromatography of the crude extract followed by mass-directed fractionation of the active fraction led to the isolation of three new compounds, scrophuloside C-D (1-2), and hebitol III (3), along with seven known compounds, namely, hebitol II (4), 8 scrophuloside B (5), 9 scrophenoside B (6), 10 scroneoside A (7), 11 picroside-I (8), 12 25-(acetyloxy)-2-(β-D-glucopyranosyloxy)-3,16,20-trihydroxy-9-methyl-19-norlanost-5-en-22-one (9), 13 and 25-(acetyloxy)-2-(β-D-glucopyranosyloxy)-3,16-dihydroxy-9-methyl-19-norlanosta-5,23-dien-22-one (10). 13 Picrohiza scrophulariiflora (Scrophulariaceae) is a perennial distributed throughout the high altitude region (over 4,400 m) in the southeast of Tibet and the northwest of Yunnan, China. The plant has been traditionally used for diarrhea, jaundice and malaria. The rihizomes of Picrorhiza scrophulariiflora (Scrophulariaceae) in this study collected from Tibet Autonomous Region, China, were purchased from Bozhou Herbal Medicine Market, Anhui Province in July, 2011. The dried and ground plant material (300g) was exhaustively extracted by MeOH, and then partitioned between petroleum ether, EtOAc and n-BuOH. Silica gel flash chromatography of the EtOAc layer yielded one active fraction which was subjected to LC-MS analysis. Mass-directed purification by reverse phase C 18 HPLC led to the isolation of nine major components, including three new metabolites, scrophuloside C (1, 4. The formation of an ether bond between the glucose moiety and the tri-substituted benzene ring was determined by the HMBC correlation from the anomeric proton (δ H 5.12) to the C-4 aromatic carbon (δ C 150.9). The planar structure of 1 was therefore elucidated as 1-O-phenyl-6-Ocinnamoyl--glucopyranoside.
The absolute configuration of the glucose moiety in 1 was determined by gas chromatography of sugar enantiomers as acetylated thiazolidine derivative. 15, 16 Acid hydrolysis of 1 followed by derivatization with L-cysteine methyl ester gave a GCMS peak at 17. C NMR data between 2 and 1 suggested that the two compounds possessed similar structural features, the differences being the absence of an acetyl methyl signal in 2 and a up-field shift of the carbonyl carbon (δ C 196.7 in 1 to δ C 167.8 in 2). These changes suggested that the acetyl functionality in 1 was replaced by a carboxylic acid in 2, which was supported by the molecular formula of 2. Using the same GCMS method as that for compound 1, the absolute configuration of the glucose in 2 was determined as -D-glucose (with a retention time of 17.96 min). The structure of scrophuloside D (2) was therefore elucidated as The planar structure of compound 3 was therefore determined to be 1-O-mannityl-6-O-cinnamoyl-ß-glucopyranose.
The GCMS analysis of a peracetylated thiazolidine derivative of the hydrolyzed 3 established a D-glucose moiety (with a retention time of 17.93 min) as in 1 and 2. The attempt to isolate the mannitol moiety form the hydrolyzed mixture, measure its optical rotation, and therefore determine the absolute configuration of mannitol was hindered by the small quantity of compound 3. Hebitol III (3) was therefore determined as 1-O-
Seven known compounds, namely hebitol II (4), 8 scrophuloside B (5), 9 scrophenoside B (6), 10 scroneoside A (7), (9), 13 and 25-(acetyloxy)-2-(β-D-glucopyranosyloxy)-3,16-dihydroxy-9-methyl-19-norlanosta-5,23-dien-22-one (10), 13 were also isolated from the active fraction of Picrorhiza scrophulariiflora. These compounds were previously reported from the plants Picrorhiza scrophulariiflora and Picrorhiza kurroa and their 1 H and 13 C NMR data were identical to those reported in the literature. The antimalarial activity of the crude extracts and the isolated pure compounds (1-10) were evaluated in vitro against P. falciparum 3D7 malaria parasites. Chloroquine was used as positive control which had an IC 50 value of 0.018 ± 0.002 μM. Compound 1-9 all had IC 50 >25 μM, while 10 had an IC 50 value of 8.3 ± 0.6 μM, and an IC 90 value of 17.3 ± 1.6 μM. Compounds 9 and 10 were the two main components in the active fraction, and the only structural difference is a double bond between C-23 and C-24. Accordingly, the presence of a α,ß-unsaturated carbonyl group in compound 10 may be important for its antimalarial activity. Since compound 10 has a Michael acceptor functionality, 19, 20 we also tested its activity against a noncancer cell line, neonatal foreskin fibroblast (NFF). It showed no cytotoxicity to NFF cells at the concentration of up to 100 M. The crude extract of Picrorhiza scrophulariiflora had 95% inhibition against P. falciparum 3D7 malaria parasites at the concentration of 10 mg/mL. A calculated IC 95 for compound 10 was obtained based on the activity of the crude extract, the percentage yield of compound 10 and its molecular weight. The results showed that the calculated IC 95 (23.5 μM) of 10 was comparable with that of the experimental IC 90 (17.3 μM) , suggesting that the antimalarial activity of this TCM, Picrorhiza scrophulariiflora, was contributed mainly by a single component. Given artemisinin (Qinghaosu) was also the single major antimalarial component identified from Artemisia annua, perhaps the anti-parasitic activity of TCM is controlled by single compounds rather than multiple components in TCMs effective against other diseases. Further isolation and activity evaluation of antimalarial Chinese herbal medicines is currently ongoing. Results will not only lead to some interesting bioactive natural products, but also shed light on whether antimalarial TCMs contain single or multiple active constituents.
